<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Heartbeam Inc — News on 6ix</title>
<link>https://6ix.com/company/heartbeam-inc</link>
<description>Latest news and press releases for Heartbeam Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 17 Apr 2026 19:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/heartbeam-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68354bf678dffbe2df0e550a.webp</url>
<title>Heartbeam Inc</title>
<link>https://6ix.com/company/heartbeam-inc</link>
</image>
<item>
<title>HeartBeam (BEAT) Closes $10M Public Offering to Advance Cardiac Technology Commercialization</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-beat-closes-dollar10m-public-offering-to-advance-cardiac-technology-commercialization</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-beat-closes-dollar10m-public-offering-to-advance-cardiac-technology-commercialization</guid>
<pubDate>Fri, 17 Apr 2026 19:00:00 GMT</pubDate>
<description>LOS ANGELES, CA - April 17, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) announced the closing of its underwritten public offering of 12.5 million shares of common stock, generating gross proceeds of $10 million before expenses, with the transactio...</description>
</item>
<item>
<title>HeartBeam Announces Closing of $10 Million Public Offering of Common Stock</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-announces-closing-of-dollar10-million-public-offering-of-common-stock</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-announces-closing-of-dollar10-million-public-offering-of-common-stock</guid>
<pubDate>Thu, 16 Apr 2026 04:00:00 GMT</pubDate>
<description>Offering was led by HeartBeam’s first commercial customer, ClearCardio™, the Company's executive leadership, board members, and existing investors SANTA</description>
</item>
<item>
<title>HeartBeam (BEAT) Launches Proposed Public Offering to Support Commercialization and AI Initiatives</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-beat-launches-proposed-public-offering-to-support-commercialization-and-ai-initiatives</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-beat-launches-proposed-public-offering-to-support-commercialization-and-ai-initiatives</guid>
<pubDate>Wed, 15 Apr 2026 19:30:00 GMT</pubDate>
<description>LOS ANGELES, CA - April 15, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care innovation, announced it is commencing an underwritten public offering of shares of its common stock or common stock equi...</description>
</item>
<item>
<title>HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-announces-pricing-of-dollar10-million-public-offering-of-common-stock</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-announces-pricing-of-dollar10-million-public-offering-of-common-stock</guid>
<pubDate>Tue, 14 Apr 2026 04:00:00 GMT</pubDate>
<description>Offering is being led by HeartBeam’s first commercial customer, ClearCardio™, the Company's executive leadership, board members, and existing investors SANTA</description>
</item>
<item>
<title>HeartBeam Announces Proposed Public Offering of Common Stock</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-announces-proposed-public-offering-of-common-stock</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-announces-proposed-public-offering-of-common-stock</guid>
<pubDate>Tue, 14 Apr 2026 04:00:00 GMT</pubDate>
<description>SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing</description>
</item>
<item>
<title>HeartBeam (BEAT) Partners With Mount Sinai to Accelerate AI-ECG Development and Validation</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-beat-partners-with-mount-sinai-to-accelerate-ai-ecg-development-and-validation</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-beat-partners-with-mount-sinai-to-accelerate-ai-ecg-development-and-validation</guid>
<pubDate>Wed, 25 Mar 2026 19:20:00 GMT</pubDate>
<description>LOS ANGELES, CA - March 25, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) recently announced a collaboration with Mount Sinai aimed at advancing artificial intelligence-driven electrocardiogram technology, marking another step in the company's push ...</description>
</item>
<item>
<title>HeartBeam (BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-beat-reports-q4-and-full-year-2025-results-advances-commercialization-and-clinical-development</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-beat-reports-q4-and-full-year-2025-results-advances-commercialization-and-clinical-development</guid>
<pubDate>Fri, 13 Mar 2026 18:12:55 GMT</pubDate>
<description>LOS ANGELES, CA - March 13, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, reported financial and operational results for the fourth quarter an...</description>
</item>
<item>
<title>HeartBeam Reports Fourth Quarter and Full Year 2025 Results</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-reports-fourth-quarter-and-full-year-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-reports-fourth-quarter-and-full-year-2025-results</guid>
<pubDate>Thu, 12 Mar 2026 20:01:00 GMT</pubDate>
<description>SANTA CLARA, Calif., March 12, 2026--HeartBeam Reports Fourth Quarter and Full Year 2025 Results</description>
</item>
<item>
<title>HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-and-mount-sinai-announce-strategic-ai-collaboration-to-bring-clinical-grade-heart-monitoring-into-the-home-2</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-and-mount-sinai-announce-strategic-ai-collaboration-to-bring-clinical-grade-heart-monitoring-into-the-home-2</guid>
<pubDate>Tue, 10 Mar 2026 11:00:00 GMT</pubDate>
<description>SANTA CLARA, Calif., March 10, 2026--HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home</description>
</item>
<item>
<title>HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-to-attend-investor-and-industry-conferences-in-march-focused-on-providing-updates-on-commercial-launch-and-unveiling-12-lead-ecg-extended-wear-patch</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-to-attend-investor-and-industry-conferences-in-march-focused-on-providing-updates-on-commercial-launch-and-unveiling-12-lead-ecg-extended-wear-patch</guid>
<pubDate>Mon, 09 Mar 2026 11:00:00 GMT</pubDate>
<description>SANTA CLARA, March 09, 2026--HeartBeam to Attend Investor and Industry Conferences in March</description>
</item>
<item>
<title>HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-announces-first-patient-enrollments-in-heart-attack-detection-pilot-study-5</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-announces-first-patient-enrollments-in-heart-attack-detection-pilot-study-5</guid>
<pubDate>Thu, 05 Mar 2026 05:00:00 GMT</pubDate>
<description>HeartBeam’s technology uniquely capable of assessing possible heart attacks outside of traditional clinical settings ALIGN-ACS study expected to complete</description>
</item>
<item>
<title>HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-to-host-fourth-quarter-full-year-2025-results-conference-call-on-thursday-march-12-2026-at-430-pm-eastern-time-84</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-to-host-fourth-quarter-full-year-2025-results-conference-call-on-thursday-march-12-2026-at-430-pm-eastern-time-84</guid>
<pubDate>Wed, 04 Mar 2026 21:01:00 GMT</pubDate>
<description>SANTA CLARA, Calif., March 04, 2026--HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time</description>
</item>
<item>
<title>HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-announces-first-commercial-customer-as-clearcardio-brings-groundbreaking-12-lead-ecg-technology-to-high-growth-preventive-cardiology-market-5</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-announces-first-commercial-customer-as-clearcardio-brings-groundbreaking-12-lead-ecg-technology-to-high-growth-preventive-cardiology-market-5</guid>
<pubDate>Wed, 04 Mar 2026 05:00:00 GMT</pubDate>
<description>Marks HeartBeam’s transition to commercial company Rapidly growing practice and highly engaged member population to enable broad adoption Enables efficient</description>
</item>
<item>
<title>HeartBeam (BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-beat-highlighted-among-medical-203000173</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-beat-highlighted-among-medical-203000173</guid>
<pubDate>Fri, 13 Feb 2026 20:30:00 GMT</pubDate>
<description>LOS ANGELES, CA - February 13, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) was recently recognized among a select group of medical device companies featured in a January industry roundup highlighting recent U.S. Food and Drug Administration ("FDA"...</description>
</item>
<item>
<title>HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-appoints-bryan-humbarger-chief-120000301</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-appoints-bryan-humbarger-chief-120000301</guid>
<pubDate>Thu, 22 Jan 2026 12:00:00 GMT</pubDate>
<description>SANTA CLARA, Calif., January 22, 2026--HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer</description>
</item>
<item>
<title>HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-attend-jp-morgan-2026-120000308</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-attend-jp-morgan-2026-120000308</guid>
<pubDate>Mon, 05 Jan 2026 12:00:00 GMT</pubDate>
<description>SANTA CLARA, Calif., January 05, 2026--HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference</description>
</item>
<item>
<title>HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-receives-fda-clearance-first-120000188</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-receives-fda-clearance-first-120000188</guid>
<pubDate>Wed, 10 Dec 2025 12:00:00 GMT</pubDate>
<description>SANTA CLARA, Calif., December 10, 2025--HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment</description>
</item>
<item>
<title>HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-provides-regulatory-path-following-213200472</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-provides-regulatory-path-following-213200472</guid>
<pubDate>Wed, 26 Nov 2025 21:32:00 GMT</pubDate>
<description>SANTA CLARA, Calif., November 26, 2025--HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application</description>
</item>
<item>
<title>HeartBeam (BEAT) Reports Q3 2025 Results as FDA Review Nears Completion and Commercial Readiness Accelerates</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-beat-reports-q3-2025-results-as-fda-review-nears-completion-and-commercial-readiness-accelerates</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-beat-reports-q3-2025-results-as-fda-review-nears-completion-and-commercial-readiness-accelerates</guid>
<pubDate>Fri, 14 Nov 2025 20:30:00 GMT</pubDate>
<description>LOS ANGELES, CA - November 14, 2025 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) reported third-quarter 2025 results and highlighted continued progress toward commercialization of its 12-lead ECG synthesis software, now in the final stage of FDA 510(k) ...</description>
</item>
<item>
<title>HeartBeam Reports Third Quarter 2025 Results</title>
<link>https://6ix.com/company/heartbeam-inc/news/heartbeam-reports-third-quarter-2025-210100148</link>
<guid isPermaLink="true">https://6ix.com/company/heartbeam-inc/news/heartbeam-reports-third-quarter-2025-210100148</guid>
<pubDate>Thu, 13 Nov 2025 21:01:00 GMT</pubDate>
<description>SANTA CLARA, Calif., November 13, 2025--HeartBeam Reports Third Quarter 2025 Results</description>
</item>
</channel>
</rss>